Statement on National Academies of Sciences, Engineering, and Medicine report on framing opioid prescribing guidelines for acute pain

https://www.fda.gov/news-events/press-announcements/statement-national-academies-sciences-engineering-and-medicine-report-framing-opioid-prescribing?utm_campaign=121919_PR_Statement%20on%20NASEM%20report%20on%20framing%20opioid%20prescribing%20guidelines&utm_medium=email&utm_source=Eloqua

Statement on National Academies of Sciences, Engineering, and Medicine report on framing opioid prescribing guidelines for acute pain

Statement from: Janet Woodcock, M.D., director of the Center for Drug Evaluation and Research. In August 2018, the U.S. Food and Drug Administration contracted the National Academies of Sciences, Engineering, and Medicine (NASEM) to help advance the development of evidence-based guidelines for opioid analgesic prescribing for acute pain resulting from specific conditions or procedures. NASEM was tasked with providing a framework to evaluate current and future opioid prescribing to support a clinical practice guideline and to identify gaps in the evidence where future research is needed. We greatly appreciate all the work done by NASEM to produce the consensus report released today. We recognize the critical role that health care providers play in addressing the opioid crisis – both in reducing the rate of new addiction by decreasing unnecessary or inappropriate exposure to opioid analgesics, while still providing appropriate pain treatment to patients who have medical needs for these medicines. However, there are still too many prescriptions written for opioid analgesics for durations of ...

Read More